Dr. Carlos Singer
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 54
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 373
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
FL license ME33954
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- HCA Florida Aventura Hospital Aventura, FL
Medical groups
- University of Miami (2,377 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 373
- Services billed
- 23,763
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 22,112 | 43 |
| Established patient office or other outpatient visit, 40-54 minutes | 240 | 193 |
| Established patient office or other outpatient visit, 30-39 minutes | 96 | 85 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 74 | 26 |
| New patient office or other outpatient visit, 60-74 minutes | 58 | 58 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 45 | 19 |
| Injection of chemical for paralysis of nerve muscles on side of face | 42 | 18 |
| Established patient office or other outpatient visit, 20-29 minutes | 21 | 21 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | 13 |
| Established patient office or other outpatient visit, 10-19 minutes | 15 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Miami, FL | 616 |
| Mirtazapine Other prescribers in Miami, FL | 154 |
| Rytary (carbidopa/levodopa) Other prescribers in Miami, FL | 121 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Miami, FL | 107 |
| Primidone Other prescribers in Miami, FL | 98 |
| Clonazepam Other prescribers in Miami, FL | 95 |
| Alprazolam Other prescribers in Miami, FL | 79 |
| Memantine Hcl Other prescribers in Miami, FL | 73 |
| Donepezil Hcl Other prescribers in Miami, FL | 73 |
| Quetiapine Fumarate Other prescribers in Miami, FL | 68 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $102 in total to this clinician.
| AbbVie Inc. | $54.55 |
|---|---|
| Merz Pharmaceuticals, LLC | $28.52 |
| Ipsen Biopharmaceuticals, Inc | $18.69 |
| Food and Beverage | $102 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $21,716 in research payments for these studies, mostly to the institutions running them.
- ITI-214-202
Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.